Sort   by:  
 Page size 
UnknownAGILE: a seamless phase I/IIa platform for the rapid evaluation of candidates for COVID-19 treatment: an update to the structured summary of a study protocol for a randomised platform trial letter.
Not available
S-EPMC8311065 | biostudies-literature
UnknownGlobal Trends in Marine Plankton Diversity across Kingdoms of Life.
Not available
S-EPMC6912166 | biostudies-literature
UnknownMedical status of 219 children with biliary atresia surviving long-term with their native livers: results from a North American multicenter consortium.
Not available
S-EPMC4144331 | biostudies-literature
UnknownTherapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
Not available
S-EPMC8362592 | biostudies-literature
UnknownSex Differences in Stroke Care and Outcomes: A National Stroke Registry Study.
Not available
S-EPMC12449931 | biostudies-literature
UnknownNeutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study.
Not available
S-EPMC9757903 | biostudies-literature
UnknownPost-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury.
Not available
S-EPMC10789589 | biostudies-literature
UnknownPhysical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study.
Not available
S-EPMC8497028 | biostudies-literature
UnknownLong term health outcomes in people with diabetes 12 months after hospitalisation with COVID-19 in the UK: a prospective cohort study.
Not available
S-EPMC11743801 | biostudies-literature
UnknownResidual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injury.
Not available
S-EPMC12860639 | biostudies-literature
Sort   by:  
 Page size